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Koki Eto*, Mitsuaki Matsumoto, Yoji Kubo and Reiko KemmochiAbstract
Surgicel, an absorbable haemostat, is widely used in cardiovascular surgery. An 81-year-old woman, who
was diagnosed with ischaemic mitral regurgitation, underwent mitral valve plasty and coronary artery
bypass grafting. On postoperative day two, her superior vena cava (SVC) pressure gradually rose to
38 mmHg and she developed low output syndrome. Emergent surgery revealed that the cause of SVC
syndrome was external compression from a haematoma at the posterior surface of the SVC, which formed
around the Surgicel.
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Haemostatic agents are quite useful in almost all surgeries.
An absorbable haemostat is also effective in controlling
oozing of suture lines or stripped surfaces. Surgicel
(Ethicon, North Ryde, NSW, Australia), an absorbable
sheet of oxidized cellulose polyanhydroglucuronic acid
polymer, has been used in numerous cardiovascular
surgeries; however, recent reports have revealed that
Surgicel can disturb organ function in several contexts
[1-4]. We report a case of superior vena cava (SVC)
syndrome due to compression by an haematoma formed
around swollen Surgicel.Case presentation
An 81-year-old Japanese woman had long been followed
for chronic heart failure. She complained of dyspnoea
during light exercise that was gradually worsening. Sub-
sequent coronary angiography demonstrated three-vessel
disease. Owing to chronic ischaemia, echocardiography
revealed diffuse hypokinesis of the left ventricle and
severe mitral regurgitation associated with the tethering of
mitral leaflets due to left ventriclar dilatation. The patient
underwent mitral valve plasty (MVP) and coronary artery* Correspondence: etouk.tchshinge@tch.or.jp
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reproduction in any medium, provided the orbypass grafting (CABG) simultaneously under a standard
medial sternotomy and a cardiopulmonary bypass (CPB)
established by cannulation of the ascending aorta, SVC, and
inferior vena cava. MVP was performed using a 24-mm
Carpenter-Edwards Physio Ring (Edwards Lifesciences,
Irvine, CA, USA) and a papillary muscle (PM) approxima-
tion, which was performed by suturing the tops of both
anterolateral and posteromedial PMs using CV-4 with felt
strips from the left atrium. CABG to the left ascending
artery, left circumflex artery, and right coronary artery
was performed using the harvested left internal thoracic
artery and saphenous vein grafts. On postoperative day two,
she suddenly showed a moon face appearance with an
increased SVC pressure of 38 mmHg. Although echo-
cardiography did not show evidence of tricuspid regurgita-
tion or SVC occlusion, computed tomography (CT)
revealed the possibility of a thrombus in the SVC (Figure 1),
and SVC angiography showed severe stenosis at the ter-
minal groove (Figure 2). Since she showed low output
syndrome and the thrombus might have caused serious
pulmonary thrombosis, emergent redo surgery was per-
formed. The anterior surface of the SVC appeared intact;
however, a haematoma was observed in the posterior side
of the SVC, which caused severe stenosis of the SVC trunk.
Careful observation revealed that the core of the haema-
toma consisted two pieces of Surgicel, which had been left
during the first operation to control the oozing of the. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and







Figure 1 Planar computed tomography. A, Coronal view. B, Axial
view. A high density area (arrow) confined at the terminal groove
was observed. A mitral ring was observed (arrowhead). Ao: aorta,
PA: pulmonary artery, LV: left ventricle, RA: right atrium, SVC: superior
vena cava.
Figure 2 Superior vena cava (SVC) angiography. Stenosis at the
SVC (arrow) and a mitral ring (arrowhead) were observed.
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The postoperative bleeding had continued and gathered
around the haemostats. After removing the haematoma,
the SVC pressure decreased immediately to 11 mmHg.
The patient’s postoperative course was uneventful.Discussion
Surgicel, an absorbable sheet of oxidized cellulose poly-
anhydroglucuronic acid polymer, has been used in many
surgical fields. Surgicel is used at surgical oozing sites,
physically promoting coagulation and producing an artifi-
cial clot [1,2].Although Surgicel is often left in surgical sites for
effective postoperative haemostasis, previous reports have
revealed that a swollen Surgicel can compress and obstruct
the function of neighbouring organs. Dogan et al. reported
a case of paraplegia following left-sided thoracotomy,
suggesting that Surgicel may migrate into the vertebral
canal and produce haematomas that result in spinal
cord compression [1]. Another report has described
the complications associated with Surgicel-produced
haematomas, including hemiparesis after trigeminal
decompression [2].
As in other surgical specialties, several cases of Surgicel-
related complications in cardiovascular surgery have been
reported [3-5]. A recent report showed that Surgicel caused
severe stenosis of a pulmonary homograft when Surgicel
was placed around the suture lines of the pulmonary artery
[4]. However, no cases of postoperative SVC syndrome
caused by Surgicel have been reported.
In most cases, SVC syndrome is associated with lung
cancer, other tumours, SVC catheters, and venous throm-
bosis, whereas postoperative SVC syndrome in cardiovas-
cular surgery is rare. In our case, the patient developed
SVC syndrome suddenly on postoperative day two. Al-
though her international normalized ratio 1.4 and activated
partial thromboplastin time 38.2 seconds were within
nornal limits, her clinical course and images on CT and
angiography suggested the possibility of catheter-associated
SVC thrombosis or stenosis caused by CPB cannulation;
however, the emergent redo surgery revealed that the
haematoma in the posterior side of the SVC was compres-
sing the SVC externally and swollen Surgicel had enhanced
compression by the haematoma. This was a finding that is
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granuloma formation occurring at a later stage of surgery.
Furthermore, in spite of no evidence of the injury of the
right pulmonary artery, a very small amount of bleeding
had continued from the sternum. In the elderly, the density
of the sternum is significantly low, which may promote
bleeding from the bone marrow postoperatively, thus
resulting in development of “Surgiceloma” [2].
Surgicel is quite useful in many haemostatic situations,
whereas the Surgicel left in surgical sites can produce
a postoperative “Surgiceloma” that can be an external
compressor, particularly in lower pressure systems or
organs such as atriums and veins. Our experience may
impress upon surgeons the importance of appropriate
use of haemostatic agents.
Conclusions
Surgeons should consider the possibility of postoperative
compression by haemostatic agents swollen with blood,
specially in lower pressure systems or organs.
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